Serologic diagnosis of ovine contagious agalactia (Mycoplasma agalactiae) with the enzymelinked immunosorbent assay (ELISA) developed by Agence Française de Sécurité Sanitaire des Aliments (AFS-SA) may produce a few false-positive (FP) and false-negative (FN) results. When the prevalence of disease is low, these erroneous results may generate problems for eradication schemes. To prevent this, 2 commercial ELISAs were compared with the AFSSA ELISA. Flocks of known status were selected and classified into 4 categories: true positive (TP), FP, true negative (TN), and FN; 20 sheep per flock were submitted for blood sampling. A flock was considered positive when at least 1 out of 20 sera was positive or 2 sera were doubtful. In the flock, the diagnostic sensitivity of the 3 kits was very good (100%), and the diagnostic specificity showed an improvement from 46% (AFSSA test) to 88% and 92% (commercial tests). Considering individual animals, very few positive ewes were detected within TN or FP flocks; the proportion of positive ewes varied greatly from one kit to another (48% to 82%) within TP flocks. The kinetics of antibody response in sheep experimentally infected with various field strains of M. agalactiae were quite similar with all 3 ELISAs. The agreement between the 3 tests, assessed using the kappa value, varied from moderate to good (respective values of 0.56, 0.61, and 0.86). The 2 commercial ELISAs showed better performances, probably because of a superior analytical sensitivity, and are a good alternative for the serodiagnosis of contagious agalactia in sheep.
Contagious agalactia is a worldwide disease of sheep and goats characterized by a decline in and subsequent failure of milk production. Other clinical signs may often be associated with mastitis and include arthritis and keratoconjunctivitis. 5 Contagious agalactia should be considered as a syndrome caused by several mycoplasmas: whereas Mycoplasma agalactiae is the most frequently isolated in sheep, Mycoplasma mycoides subsp. mycoides Large Colony and Mycoplasma capricolum subsp. capricolum can induce similar clinical presentations. 1 Under some conditions, Mycoplasma putrefaciens may also be a causative agent of contagious agalactia in goats. 2 The importance of contagious agalactia varies across its extensive geographical distribution and according to the size of the ewe and goat flocks. Mediterranean countries are particularly affected because they have many sheep and goat dairy flocks. In France, classical contagious agalactia (due to M. agalactiae) in sheep and goats persists residually in 2 regions. Over the last 11 years, attempts to control or even eradicate the disease in these regions have involved a combination of complementary measures: compulsory notification of clinical suspicions by regular clinical examination of flocks with signs suggesting contagious agalactia, laboratory confirmation by identification of the organism and by enzyme-linked immunosorbent assay (ELISA) serology, culling or confinement of infected flocks, annual assessment of flock status by ELISA serology, and sometimes bulk-milk bacteriology. This policy has led to a From the Agence Française de Sécurité Sanitaire des Aliments (AFSSA), F-06902 Sophia Antipolis, France (Pépin, Dufour, Lambert, Aubert), the Laboratoire Départemental d'Analyses, F-64010 Pau, France (Valognes), the ADMA, F-64000 Pau, France (Rotis, Van de Wiele), and the National Veterinary School, INRA-UMR 959, F-31076 Toulouse, France (Bergonier). significant decrease in disease prevalence. In the Pyrénées-Atlantiques area, for example, the percentage of infected flocks has declined from 10% to less than 1% in 11 years. 7 In these control programs, the serologic testing is performed once or twice a year for each flock. For this purpose, 20 randomly taken sera per flock are tested with an ELISA technique developed by the Agence Française de Sécurité Sanitaire des Aliments (AFSSA) Sophia Antipolis laboratory. 4, 6 After transformation of the optical densities (ODs) into units using dilutions of a reference positive serum, individual titers are used to determine a flock index. This index, together with bulk-milk bacteriology in and around outbreak areas, is used to classify flocks into 4 categories: ''free of agalactia,'' ''presumed free,'' ''infected,'' and ''heavily infected.'' 8 However, in several instances, this serological index wrongly classifies flocks as revealed by bacteriological or epidemiological observations. Because serology remains the only practical tool for defining the flock status, the current low prevalence of contagious agalactia (Ͻ1%) calls for a more specific and sensitive test. To assess the diagnostic performance of 2 commercially available ELISA kits for detection of M. agalactiae antibodies in comparison with the AFSSA ELISA, sera collected from various flocks and from experimentally infected sheep were titrated using all the 3 ELISA kits in parallel.
Following the previous campaign of serologic examination, 1,017 sheep sera were selected from the field collection stored at Ϫ20 C. All the sera came from 52 different flocks of the Pyrénées-Atlantiques region, where mycoplasmas other than M. agalactiae have never been isolated from small ruminants. These flocks, whose status during the last 10 years is well known, have been divided into 4 categories according to their status: true positive (TP), true negative (TN), false positive (FP), and false negative (FN). This status 
* Bacteriological examination was performed on bulk milk. † Epidemiological context was evaluated according to 1) the geographical location of the flock and 2) the historical record of contagious agalactia in this flock and in neighboring flocks during the last 10 years.
‡ Serologic testing was performed with the AFSSA ELISA kit. * The recombinant antigen is the P48 antigen recognized as an immunodominant one 9;10 ; it was expressed in fusion with glutathione-Stransferase for the purification step.
† International reference strain. ‡ Transformation of ODs into units was performed as previously described. 4 was established according to 4 criteria: 1) AFSSA ELISA titers and flock index during the previous campaign, 2) bacteriological examinations of bulk milk during the previous campaign, 3) clinical signs of contagious agalactia and isolation of M. agalactiae, and 4) epidemiological analysis of each situation according to the geographical and historical context (presence or absence of contagious agalactia outbreaks or infection in the area or in the neighboring area during the last 10 years) ( Table 1) . Flocks with an uncertain agalactia history were excluded.
Sera from experimentally infected sheep were obtained after intramammary inoculation of groups of 5 ewes with various field isolates of M. agalactiae. The protocol and results of this experimental infection were previously reported. 11 For the present study, these sera were tested again, using the 3 ELISA kits in parallel and after storage at Ϫ20 C for several months.
The ELISA kits used in this study are henceforth referred to as AFSSA (AFSSA Sophia Antipolis kit), POURQ (Pourquier Institute a kit), and INTER (Intervet b kit). Each assay was performed according to the manufacturer's instructions and following the regulations of the Quality Accreditation scheme for the immunoserology program of the French Committee for Accreditation (COFRAC; program no. 109). The main characteristics of the 3 ELISA kits are summarized in Table 2 . For each test, the same positive and negative control sera were used in each plate. The cutoff values to differentiate negative and positive sera were defined as the median value of the interval defined as doubtful by the manufacturer for the 2 commercial kits. For the AFSSA kit, the cutoff value had been previously defined (Table 2) . 4, 6 A flock was considered positive when at least 1 out of 20 sera was positive or, in the absence of positive serum, when 2 sera were doubtful.
The 3 tests were assessed at both individual and flock levels. Calculation of diagnostic sensitivity (D-SN) and diagnostic specificity (D-SP) was performed according to the principles of validation of diagnostic assays for infectious diseases recommended by the Office International des Epizooties. 3 Agreement between tests was assessed by calculating the kappa value. 13 To evaluate the D-SN and D-SP of each test, only 3 categories of flocks (TP, TN, and FP) were used because flocks classified as FN were positive for one other diagnostic criterion, whereas serology was negative with the AFSSA kit. For individual sera, D-SP was good for all 3 ELISA kits (94% to 99%; Table 3 ). In particular, the specificity of the 2 commercial kits POURQ and INTER was 99%. This result indicates that with these tests, in negative flocks, very few cross-reactions occur with saprophytic or pathogenic mollicutes or with other microbial antigens. In terms of the flocks, the D-SP values were not so good, particularly for the AFS-SA kit, but were satisfactory for the others (46% to 92%; Table 4 ). This apparent discrepancy may be easily explained-a few positive sera in uninfected flocks led to the misclassification of 2 (POURQ), 3 (INTER), and 12 (AFS-SA) flocks out of 26 because the criteria used to declare a flock positive were severe, i.e., 1 positive serum or 2 doubtful sera. The situation was reversed for D-SN: although all positive flocks were recognized as positive (D-SN ϭ 100% for the 3 tests; Table 4 ), D-SN values for the individual sera were lower (48% to 82%). Not all the 20 sera from infected flocks were positive, as expected. This may be explained by the normal evolution of the disease where clinical signs and production of antibodies are dependent on 1) the age of animals, the physiological status and lactation stage, the immune status of animals, and the interval between contamination and blood sampling and 2) external factors such as the infection pressure and husbandry factors. 1 Thus, true seronegative ewes may exist in infected flocks. Nevertheless, considered in parallel with the good specificity values, the commercial kits represent a significant improvement in analytical sensitivity, particularly for low-prevalence situations. Examination of data of the FN category yielded some other interesting results because the POURQ and INTER tests detected more positive sera: 43 (POURQ) and 26 (INTER) versus 6 (AFSSA) out of 188 or 219 sera (P Ͻ 0.001 for POURQ or INTER vs. AFSSA; chi-square test). Again, these results could be a consequence of the better analytical sensitivity of the POURQ and INTER tests, which detect lower titers and newly infected animals earlier.
The agreement between the 3 tests determined by the kappa value was moderate (0.562, AFSSA vs. POURQ), substantial (0.609, AFSSA vs. INTER), or almost perfect (0.863, POURQ vs. INTER) ( Table 5 ), according to the arbitrary benchmarks for evaluating observed kappa values. 13 With sera from experimentally infected ewes, the 3 ELISAs detected a significant increase in antibody response between days 4 and 11 after inoculation. However, average titers after seroconversion remained close to the positive threshold for the AFSSA kit. The 2 other ELISA kits discriminated well between negative (before inoculation) and positive sera (after inoculation) (Fig. 1) . The 3 kits provided similar antibody kinetics against each of the 6 strains of M. agalactiae tested during this experiment (data not shown). Interestingly, the seroconversion occurred at roughly the same time after inoculation for the whole-antigen kits and the recombinant kit. The duration of antibody responses should now be investigated with the 2 types of tests.
Repeatability was calculated by including replicates in the same plate or in different plates; coefficients of variation, less than 15% for each kit, indicated adequate repeatability.
Reproducibility of the 3 tests was determined by compar-ing data, obtained from 2 different laboratories, for the 1,017 sera included in this report. The performances of the 3 kits were compared by calculating a correlation factor: results were good (AFSSA, r ϭ 0.901; INTERVET, r ϭ 0.892) or excellent (POURQ, r ϭ 0.950).
In the context of contagious agalactia control programs in sheep, the 3 tests are not quite similar. When contagious agalactia was quite prevalent, the AFSSA ELISA kit gave excellent results, leading to a significant decrease in disease prevalence in recent years, 6 whereas during these campaigns, several epidemiological observations have demonstrated this kit's lack of sensitivity. This limitation was demonstrated when the test failed to detect antibodies in young sheep experimentally infected with a fully virulent strain of M. agalactiae. 12 Because the prevalence of contagious agalactia in the French regions where control programs have been implemented is currently very low, there is a need for more efficient serologic tools, such as the 2 commercially available kits presented in this study. For these ELISAs, the performances are very satisfactory probably because of a better choice or preparation of the antigen used to coat the ELISA microplates. The POURQ kit's use of a recombinant and immunodominant protein, the P48 major surface protein, 9, 10 may explain its good specificity and sensitivity with our panel of sera.
In conclusion, the 2 commercial kits, POURQ and IN-TER, tested in this study have demonstrated good performance characteristics and excellent agreement (kappa value ϭ 0.863). The different regions involved in contagious aga- Table 2) . lactia prophylaxis will choose 1 of the 2 commercial kits to continue disease control and gradually achieve disease-free status and, hopefully, eradication.
